BriaCell Therapeutics (BCTX) Price/OCF Ratio: History & Chart

Basis: FMP quote market capitalization / four-quarter operating cash flow. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/OCF ratio is N/A as of 2026-10-06T15:45:45.054Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:45:45.054Z.

Quote observation: 2026-10-06T15:44:34.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 35,321,147
TTM operating cash flow · period ending 2026-04-30: -36,938,635

FMP input reference: 8e18e4937bb179ad65bb801f5f057f36d78bd2e4af2c39ec5cecdad017acf428

P/E Ratio|P/FCF Ratio|Operating Cash Flow|Operating Margin|All Metrics

BCTX Price/OCF Ratio Metrics

PRICE/OCF RATIO

N/A

BCTX Competitors' Price/OCF Ratio

BCTX

BriaCell Therapeutics Corp.

Current

Market Cap

$35.32M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

DCGO

DocGo Inc.

vs BCTX

Market Cap

$35.78M

Price/OCF Ratio

N/A

TTM Avg

2.00

3Y Avg

3.35

5Y Avg

33.77

QTI

QT Imaging Holdings, Inc.

vs BCTX

Market Cap

$35.80M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ARAY

Accuray Incorporated

vs BCTX

Market Cap

$34.50M

Price/OCF Ratio

N/A

TTM Avg

17.67

3Y Avg

45.36

5Y Avg

32.48

GRCE

Grace Therapeutics, Inc.

vs BCTX

Market Cap

$34.34M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELUT

Elutia Inc

vs BCTX

Market Cap

$35.54M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ELTX

Elicio Therapeutics, Inc.

vs BCTX

Market Cap

$36.80M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALGS

Aligos Therapeutics, Inc.

vs BCTX

Market Cap

$33.66M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

EDSA

Edesa Biotech, Inc.

vs BCTX

Market Cap

$37.28M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BEAT

HeartBeam, Inc.

vs BCTX

Market Cap

$32.75M

Price/OCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/OCF RATIO	TTM	3Y	5Y
BriaCell Therapeutics Corp. (BCTX)	$35.32M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$35.78M	N/A	2.00	3.35	33.77
QT Imaging Holdings, Inc. (QTI)vs ›	$35.80M	N/A	N/A	N/A	N/A
Accuray Incorporated (ARAY)vs ›	$34.50M	N/A	17.67	45.36	32.48
Grace Therapeutics, Inc. (GRCE)vs ›	$34.34M	N/A	N/A	N/A	N/A
Elutia Inc (ELUT)vs ›	$35.54M	N/A	N/A	N/A	N/A
Elicio Therapeutics, Inc. (ELTX)vs ›	$36.80M	N/A	N/A	N/A	N/A
Aligos Therapeutics, Inc. (ALGS)vs ›	$33.66M	N/A	N/A	N/A	N/A
Edesa Biotech, Inc. (EDSA)vs ›	$37.28M	N/A	N/A	N/A	N/A
HeartBeam, Inc. (BEAT)vs ›	$32.75M	N/A	N/A	N/A	N/A

Price/OCF Ratio Formula & Definition

P/OCF measures market price relative to operating cash flow: market cap divided by TTM operating cash flow. OCF is cash from operations before capital expenditures, so it sits above free cash flow — P/OCF typically reads below P/FCF, with the widest gap for capex-heavy businesses.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/OCF Ratio: N/A

BCTX Price/OCF Ratio Metrics

BCTX Competitors' Price/OCF Ratio

Operating Cash Flow Valuation

Price/OCF Ratio Formula & Definition

Related Metrics